<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01145872</url>
  </required_header>
  <id_info>
    <org_study_id>F32AT004879-01A2</org_study_id>
    <nct_id>NCT01145872</nct_id>
  </id_info>
  <brief_title>The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression Relapse</brief_title>
  <acronym>MBCT</acronym>
  <official_title>The Effects and Mechanisms of MBCT on Depressive Symptoms and Depression Relapse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Boulder</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research proposal is intended to elucidate the efficacy and mechanisms underlying&#xD;
      Mindfulness Based Cognitive Therapy (MBCT) in a population in remission from recurrent Major&#xD;
      Depressive Disorder (MDD). The first objective of the study is to replicate previous studies'&#xD;
      findings of MBCT's effects on decreasing depressive symptoms and depression relapse rates.&#xD;
      However, this proposal aims to make a novel contribution to the literature by using a&#xD;
      randomized, controlled design, and comparing the effects of MBCT to an active control&#xD;
      condition (ACC). The use of a well-designed ACC will enable us to control for confounding&#xD;
      variables such as social support and expected outcomes, thus allowing us to determine whether&#xD;
      elements specific to MBCT lead to its salutary effects (Aim 1). Previous MBCT studies have&#xD;
      largely relied on self-report measurement methodologies, limiting valid conclusions about the&#xD;
      nature of MBCT. Further, few studies have examined the mechanisms underlying effects of MBCT&#xD;
      on depressive symptoms and relapse. Theoretical considerations and preliminary empirical&#xD;
      evidence suggest emotional, physiological, and cognitive functioning to be promising&#xD;
      mechanisms of MBCT. Therefore, the investigators propose to assess each of these potential&#xD;
      mechanisms of MBCT using self-report, autonomic physiological, and reaction time tasks (Aim&#xD;
      2). Collectively, these aims are expected to strengthen the evidence base for MBCT while&#xD;
      cultivating a scientific model for its effects and mechanisms on decreasing depressive&#xD;
      symptoms and depression relapse rates.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depression Relapse</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depressive Symptoms</measure>
    <time_frame>1 Year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Major Depressive Disorder</condition>
  <condition>Recurrent</condition>
  <arm_group>
    <arm_group_label>Mindfulness Based Cognitive Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Health Enhancement Program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness Based Cognitive Therapy</intervention_name>
    <arm_group_label>Mindfulness Based Cognitive Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Health Enhancement Program</intervention_name>
    <arm_group_label>Health Enhancement Program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  must comprehend English well&#xD;
&#xD;
          -  be 18-55 years of age&#xD;
&#xD;
          -  meet enhanced DSM-IV criteria for remission of MDD, recurrent and have a history of&#xD;
             three or more previous episodes of DSM-IV major depression in the absence of a history&#xD;
             of mania or hypomania&#xD;
&#xD;
          -  at least one of those episodes was within the past two years&#xD;
&#xD;
          -  participant must be in remission and if on antidepressant medication (ADM), they must&#xD;
             be on a stable dose with no change in type or amount for past 12 weeks or participants&#xD;
             must be off ADM at T1 for at least the preceding 12 weeks&#xD;
&#xD;
          -  have, at screening assessment, residual depressive symptoms indicated by a Beck&#xD;
             Depression Inventory-II (BDI-II;[72]) score between 6-19.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  bipolar disorder&#xD;
&#xD;
          -  schizophrenia or borderline personality disorder&#xD;
&#xD;
          -  current suicidal thoughts and/or suicide attempt in last two months&#xD;
&#xD;
          -  current anxiety disorder if it constitutes the predominant aspect of the clinical&#xD;
             presentation and requires primary treatment not offered in the project&#xD;
&#xD;
          -  substance abuse or dependence within last three months&#xD;
&#xD;
          -  dementia or subnormal intellectual potential&#xD;
&#xD;
          -  current obsessive-compulsive disorder&#xD;
&#xD;
          -  current eating disorder&#xD;
&#xD;
          -  history of previous mindfulness training or more than eight lifetime sessions of CBT&#xD;
&#xD;
          -  current use of psychotherapy or counseling&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Denver</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <study_first_submitted>June 16, 2010</study_first_submitted>
  <study_first_submitted_qc>June 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2010</study_first_posted>
  <last_update_submitted>December 1, 2014</last_update_submitted>
  <last_update_submitted_qc>December 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Denver</investigator_affiliation>
    <investigator_full_name>Amanda Shallcross</investigator_full_name>
    <investigator_title>Post-Doctoral Researcher</investigator_title>
  </responsible_party>
  <keyword>Mindfulness</keyword>
  <keyword>clinical trial</keyword>
  <keyword>intervention</keyword>
  <keyword>prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

